Where I see patients (3)
My reviews
Selected research
-
Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
-
The human microbiome and gut-liver axis in people living with HIV.
Current HIV/AIDS reports
-
Immunogenicity and Safety of Hepatitis B vaccine with a Toll-like Receptor 9 Agonist Adjuvant (HEPLISAV-B) in HBV Vaccine-naive People with HIV.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Clinical trials
Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
Prevalence of hepatic steatosis in PLWH will be reported as the number of participants with hepatic steatosis, defined by controlled attenuation parameter (CAP) ≥263 dB/m, over the total number of participants assessed.
Recruiting
4.9